Statistics for Ascendis Pharma A/S (id:7370 ASND)
Valuation metrics
Market cap
8.24B
Enterprise value
7.98B
Trailing P/E (ttm)
-15.95
Forward P/E
-34.87
PEG ratio
-34.87
Price/Sales (ttm)
25.93
Price/Book (mrq)
-77.31
Enterprise Value/Revenue
24.14
Enterprise Value/EBITDA
-22.09
Overview
Shares outstanding
59.80M
Float
56.93M
Shares short
3.41M
% Held by insiders
5.00%
% Held by institutions
1.07%
Average volume (10 days)
444.29K
Average volume (90 days)
Price summary
52-Week low
111.09
52-Week high
161.00
52-Week change
6.79%
Beta
3.00
50-Day moving average
129.42
200-Day moving average
135.16
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-154.12%
Operating margin
-370.18%
Operational effectiveness
Return on assets
-27.92%
Return on equity
330.44%
Income statement
Revenue (ttm)
5.60
Revenue per share (ttm)
5.60
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
222.32M
EBITDA
-361,357,771.00
Net income to common (ttm)
-509,487,273.00
Diluted EPS (ttm)
-7.82
Quarterly earnings growth (yoy)
20.40%
Balance sheet
Total cash (mrq)
269.25M
Total cash per share (mrq)
4.51
Total debt (mrq)
700.08M
Total Debt/Equity (mrq)
-7.19
Current ratio (mrq)
74.00%
Book value per share (mrq)
-2.57
Cash flow
Cash flow statement
-343,545,571.00
Levered free cash flow (LFCF)
-108,376,730.00